Abstract
While the characterization of the physicochemical properties of a nanocarrier as presented in Chap. 3 is crucial to the evaluation and subsequent optimization of the carrier performance, as the ultimate goal of the development of a carrier is to enhance the efficiency of systemic delivery in a biological body, in vivo assessment of the carrier is unavoidable. In vivo assessment gives information about the mechanism of action, pharmacokinetics, and pharmacodynamics of the agent administered. Over the years, many animal models have been used for studying the in vivo performance of a drug, which in this case is either a free drug or a drug that has been pre-loaded into a carrier. Rodents like rats, mice, guinea pigs, and rabbits are the commonly used animals. Recently, zebrafish invertebrate models have also been established and used in in vivo studies. They are now used widely as a screening model to assess the in vivo performance of many drugs. Regarding the importance of in vivo assessment in the design and use of systemic delivery technologies in anti-aging medicine, in this chapter, we will describe the various in vivo techniques for the assessment of drug delivery.
V. K. Ameena Shirin and Renu Sankar: These authors have contributed equally to this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdel-Messih HA, Ishak RAH, Geneidi AS, Mansour S (2019) Tailoring novel soft nano-vesicles ‘Flexosomes’ for enhanced transdermal drug delivery: optimization, characterization and comprehensive ex vivo—in vivo evaluation. Int J Pharm 560:101–115. https://doi.org/10.1016/j.ijpharm.2019.01.072
AboulFotouh K, Allam AA, El-Badry M, El-Sayed AM (2019) A self-nanoemulsifying drug delivery system for enhancing the oral bioavailability of candesartan cilexetil: ex vivo and in vivo evaluation. J Pharm Sci 108:3599–3608. https://doi.org/10.1016/j.xphs.2019.07.004
Ahmed OAA, Badr-Eldin SM (2019) Development of an optimized avanafil-loaded invasomal transdermal film: ex vivo skin permeation and in vivo evaluation. Int J Pharm 570:118657. https://doi.org/10.1016/j.ijpharm.2019.118657
Andersen CA, Perfetti P, Nibbio M, Bellini M, Angelini R, Fornasier M (2014) Brain penetration assessment in vivo: a reliable and simple method in anesthetized rats at steady state. J Neurosci Methods 232:199–206. https://doi.org/10.1016/j.jneumeth.2014.04.022
Asari S, Fujimoto K, Kato S, Mizukami H, Ikeguchi K, Kawakami T, Urabe M, Kume A, Watanabe E, Sato T, Ozawa K, Nakano I, Muramatsu S (2010) In vivo assessment of the aromatic L-amino acid decarboxylase gene expression by positron emission tomography in Parkinson’s disease. Neurosci Res 68:e66. https://doi.org/10.1016/j.neures.2010.07.058
Ávalos A, Haza AI, Mateo D, Morales P (2018) In vitro and in vivo genotoxicity assessment of gold nanoparticles of different sizes by comet and SMART assays. Food Chem Toxicol 120:81–88. https://doi.org/10.1016/j.fct.2018.06.061
Bangeppagari M, Park SH, Kundapur RR, Lee SJ (2019) Graphene oxide induces cardiovascular defects in developing zebrafish (Danio rerio) embryo model: In vivo toxicity assessment. Sci Total Environ 673:810–820. https://doi.org/10.1016/j.scitotenv.2019.04.082
Bhardwaj P, Sidhu PK, Lonare MK, Kaur R, Dumka VK, Rampal S (2018) Pharmacokinetic-pharmacodynamic integration of marbofloxacin after single and repeated intravenous administration in goats. Res Vet Sci 121:111–115. https://doi.org/10.1016/j.rvsc.2018.10.010
Brake K, Gumireddy A, Tiwari A, Chauhan H, Kumari D (2017) In vivo studies for drug development via oral delivery: challenges, animal models and techniques. Pharm Anal Acta 8:560. https://doi.org/10.4172/2153-2435.1000560
Brantley N, Lessman CA (2019) In vivo assessment of gonad status, secondary sex characteristics and spawning in transparent Casper zebrafish. Mech Dev 160:103582. https://doi.org/10.1016/j.mod.2019.103582
Brinkhous KM, Graham JB (1950) Hemophilia in the female dog. Sci 111:723–724
Brunner M, Langer O (2006) Microdialysis versus other techniques for the clinical assessment of in vivo tissue drug distribution. AAPS J 8:E263–E271. https://doi.org/10.1007/BF02854896
Caro LG, Van Tubergen RP, Kolb JA (1962) High-resolution autoradiography. I. Methods, J Cell Biol 15:173–188. https://doi.org/10.1016/B978-1-4832-2795-5.50017-4
Cheng Y, Xu Z, Ma M, Xu T (2008) Dendrimers as drug carriers: applications in different routes of drug administration. J Pharm Sci 97:123–143. https://doi.org/10.1002/jps.21079
Chen F, Xu Z, Lu J, Lü X, Mu W, Wang Y, Liu D, Liang C (2010) Gaussia luciferase reporter assay for assessment of gene delivery systems in vivo. Chinese Med Sci J 25:95–99. https://doi.org/10.1016/S1001-9294(10)60029-6
Chockalingam A, Xu L, Stewart S, LeMerdy M, Tsakalozou E, Fan J, Patel V, Rouse R (2019) Protocol for evaluation of topical ophthalmic drug products in different compartments of fresh eye tissues in a rabbit model. J Pharmacol Toxicol Methods 96:9–14. https://doi.org/10.1016/j.vascn.2018.12.002
Chow PKH, Ng RTH, Ogden BE (2008) Using animal models in biomedical research. World Scientific Publishing, China. 10.1142/6454
Cobice DF, Goodwin RJA, Andren PE, Nilsson A, Mackay CL, Andrew R (2015) Future technology insight: mass spectrometry imaging as a tool in drug research and development. Br J Pharmacol 172:3266–3283. https://doi.org/10.1111/bph.13135
Cook N, Jodrell DI, Tuveson DA (2012) Predictive in vivo animal models and translation to clinical trials. Drug Discov Today 17:253–260. https://doi.org/10.1016/j.drudis.2012.02.003
Crudele JM, Finn JD, Siner JI, Martin NB, Niemeyer GP, Zhou S, Mingozzi F, Lothrop CD Jr, Arruda VR (2015) AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and mice. Blood 125:1553–1561. https://doi.org/10.1182/blood-2014-07-588194
Davidson M, Lindsey J, Davis J (1987) Requirements and selection of an animal model. Isr J Med Sci 23:551–555
Delvecchio C, Tiefenbach J, Krause HM (2011) The zebrafish: a powerful platform for in vivo, HTS drug discovery. Assay Drug Dev Technol 9:354–361. https://doi.org/10.1089/adt.2010.0346
Desai S, Bolton S (1993) A floating controlled-release drug delivery system: in vitro-in vivo evaluation. Pharm Res 10:1321–1325. https://doi.org/10.1023/a:1018921830385
Destruel P-L, Zeng N, Maury M, Mignet N, Boudy V (2017) In vitro and in vivo evaluation of in situ gelling systems for sustained topical ophthalmic delivery: State of the art and beyond. Drug Discov Today 22:638–651. https://doi.org/10.1016/j.drudis.2016.12.008
Deutel B, Greindl M, Thaurer M, Bernkop-Schnürch A (2008) Novel insulin thiomer nanoparticles: in vivo evaluation of an oral drug delivery system. Biomacromol 9:278–285. https://doi.org/10.1021/bm700916h
dos Santos Rodrigues B, Oue H, Banerjee A, Kanekiyo T, Singh J (2018) Dual functionalized liposome-mediated gene delivery across triple co-culture blood brain barrier model and specific in vivo neuronal transfection. J Control Release 286:264–278. https://doi.org/10.1016/j.jconrel.2018.07.043
Drummond IA (2005) Kidney development and disease in the zebrafish. J Am Soc Nephrol 16:299–304. https://doi.org/10.1681/ASN.2004090754
El-Feky GS, El-Naa MM, Mahmoud AA (2019) Flexible nano-sized lipid vesicles for the transdermal delivery of colchicine; in vitro/in vivo investigation. J Drug Deliv Sci Technol 49:24–34. https://doi.org/10.1016/j.jddst.2018.10.036
Erdő F, Bors LA, Farkas D, Bajza Á, Gizurarson S (2018) Evaluation of intranasal delivery route of drug administration for brain targeting. Brain Res Bull 143:155–170. https://doi.org/10.1016/j.brainresbull.2018.10.009
Frangioudakis G, Gyte AC, Loxham SJG, Poucher SM (2008) The intravenous glucose tolerance test in cannulated Wistar rats: a robust method for the in vivo assessment of glucose-stimulated insulin secretion. J Pharmacol Toxicol Methods 57:106–113. https://doi.org/10.1016/j.vascn.2007.12.002
Freag MS, Saleh WM, Abdallah OY (2018) Laminated chitosan-based composite sponges for transmucosal delivery of novel protamine-decorated tripterine phytosomes: ex vivo mucopenetration and in-vivo pharmacokinetic assessments. Carbohydr Polym 188:108–120. https://doi.org/10.1016/j.carbpol.2018.01.095
Garhy DMA, Ismail S, Ibrahim HK, Ghorab MM (2018) Buccoadhesive gel of carvedilol nanoparticles for enhanced dissolution and bioavailability. J Drug Deliv Sci Technol 47:151–158. https://doi.org/10.1016/j.jddst.2018.07.009
Giles AR, Tinlin S, Greenwood R (1982) A canine model of hemophilic (factor VIII: C deficiency) bleeding. Blood 60:727–730. https://doi.org/10.1182/blood.V60.3.727.bloodjournal603727
Graham JB, Buckwalter JA (1949) Canine hemophilia; observations on the course, the clotting anomaly, and the effect of blood transfusions. J Exp Med 90:97–111. https://doi.org/10.1084/jem.90.2.97
Guengerich FP (1997) Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species. Chem Biol Interact 106:161–182. https://doi.org/10.1016/s0009-2797(97)00068-9
Guggi D, Krauland AH, Bernkop-Schnürch A (2003) Systemic peptide delivery via the stomach: in vivo evaluation of an oral dosage form for salmon calcitonin. J Control Release 92:125–135. https://doi.org/10.1016/S0168-3659(03)00299-2
Gustafsson S, Eriksson J, Syvänen S, Eriksson O, Hammarlund-Udenaes M, Antoni G (2017) Combined PET and microdialysis for in vivo estimation of drug blood-brain barrier transport and brain unbound concentrations. Neuroimage 155:177–186. https://doi.org/10.1016/j.neuroimage.2017.04.068
Helmy AM, Elsabahy M, Soliman GM, Mahmoud MA, Ibrahim EA (2017) Development and in vivo evaluation of chitosan beads for the colonic delivery of azathioprine for treatment of inflammatory bowel disease. Eur J Pharm Sci 109:269–279. https://doi.org/10.1016/j.ejps.2017.08.025
Ho MJ, Lee DR, Im SH, Yoon JA, Shin CY, Kim HJ, Jang SW, Choi YW, Han YT, Kang MJ (2018) Design and in vivo evaluation of entecavir-3-palmitate microcrystals for subcutaneous sustained delivery. Eur J Pharm Biopharm 130:143–151. https://doi.org/10.1016/j.ejpb.2018.06.024
Hofling A, Devine S, Vogler C, Sands M (2003) In vivo assessment of the efficacy of gene therapy targeted to diseased human hematopoietic progenitor cells in a xenotransplantable murine model of a lysosomal storage disorder. Mol Ther 7:S81–S82. https://doi.org/10.1016/S1525-0016(16)40649-0
Hussain Z, Katas H, Mohd Amin MCI, Kumolosasi E, Buang F, Sahudin S (2013) Self-assembled polymeric nanoparticles for percutaneous co-delivery of hydrocortisone/hydroxytyrosol: an ex vivo and in vivo study using an NC/Nga mouse model. Int J Pharm 444:109–119. https://doi.org/10.1016/j.ijpharm.2013.01.024
Karkossa F, Klein S (2019) Individualized in vitro and in silico methods for predicting in vivo performance of enteric-coated tablets containing a narrow therapeutic index drug. Eur J Pharm Biopharm 135:13–24. https://doi.org/10.1016/j.ejpb.2018.12.004
Kashiwakura Y, Mimuro J, Onishi A, Iwamoto M, Madoiwa S, Fuchimoto D, Suzuki S, Suzuki M, Sembon S, Ishiwata A, Yasumoto A, Sakata A, Ohmori T, Hashimoto M, Yazaki S, Sakata Y (2012) Porcine model of hemophilia A. PLoS ONE 7:e49450. https://doi.org/10.1371/journal.pone.0049450
Kaur R, Ajitha M (2019) Transdermal delivery of fluvastatin loaded nanoemulsion gel: preparation, characterization and in vivo anti-osteoporosis activity. Eur J Pharm Sci 136:104956. https://doi.org/10.1016/j.ejps.2019.104956
Kim MS, Haney MJ, Zhao Y, Yuan D, Deygen I, Klyachko NL, Kabanov AV, Batrakova EV (2018) Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations. Nanomed Nanotechnol Biol Med 14:195–204. https://doi.org/10.1016/j.nano.2017.09.011
Kirienko NV, Mani K, Fay DS (2010) Cancer models in caenorhabditis elegans. Dev Dyn 239:1413–1448. https://doi.org/10.1002/dvdy.22247
Krauland AH, Leitner VM, Grabovac V, Bernkop-Schnürch A (2006) cJ Pharm Sci 95:2463–2472. https://doi.org/10.1002/jps.20700
Kucherlapati R (2012) Genetically modified mouse models for biomarker discovery and preclinical drug testing. Clin Cancer Res 18:625–630. https://doi.org/10.1158/1078-0432.CCR-11-2021
Lanao JM, Fraile MA (2005) Drug tissue distribution: Study methods and therapeutic implications. Curr Pharm Des 11:3829–3845. https://doi.org/10.2174/138161205774580679
Ledgerwood DN, DePeters EJ, Robinson PH, Taylor SJ, Heguy JM (2009) Assessment of a brown midrib (BMR) mutant gene on the nutritive value of sudangrass using in vitro and in vivo techniques. Anim Feed Sci Technol 150:207–222. https://doi.org/10.1016/j.anifeedsci.2008.10.001
Li J, Le W (2013) Modeling neurodegenerative diseases in Caenorhabditis elegans. Exp Neurol 250:94–103. https://doi.org/10.1016/j.expneurol.2013.09.024
Li J, Zheng H, Li X, Su J, Qin L, Sun Y, Guo C, Beck-Broichsitter M, Moehwald M, Chen L, Zhang Y, Mao S (2019) Phospholipid-modified poly(lactide-co-glycolide) microparticles for tuning the interaction with alveolar macrophages: in vitro and in vivo assessment. Eur J Pharm Biopharm 143:70–79. https://doi.org/10.1016/j.ejpb.2019.08.017
Lieschke GJ, Currie PD (2007) Animal models of human disease: zebrafish swim into view. Nat Rev Genet 8:353–367. https://doi.org/10.1038/nrg2091
Linnik IV, Rayner PJ, Stow RA, Duckett SB, Cheetham GMT (2019) Pharmacokinetics of the SABRE agent 4,6–d2-nicotinamide and also nicotinamide in rats following oral and intravenous administration. Eur J Pharm Sci 135:32–37. https://doi.org/10.1016/j.ejps.2019.05.004
Liu S, Leach SD (2011) Zebrafish models for cancer. Annu Rev Pathol Mech Dis 6:71–93. https://doi.org/10.1146/annurev-pathol-011110-130330
Liu J-M, Zhang D-D, Fang G-Z, Wang S (2018) Erythrocyte membrane bioinspired near-infrared persistent luminescence nanocarriers for in vivo long-circulating bioimaging and drug delivery. Biomaterials 165:39–47. https://doi.org/10.1016/j.biomaterials.2018.02.042
Loxham SJG, Teague J, Poucher SM, De Schoolmeester J, Turnbull AV, Carey F (2007) Glucagon challenge in the rat: a robust method for the in vivo assessment of glycogen phosphorlyase inhibitor efficacy. J Pharmacol Toxicol Methods 55:71–77. https://doi.org/10.1016/j.vascn.2006.03.005
Matbou Riahi M, Sahebkar A, Sadri K, Nikoofal-Sahlabadi S, Jaafari MR (2018) Stable and sustained release liposomal formulations of celecoxib: in vitro and in vivo anti-tumor evaluation. Int J Pharm 540:89–97. https://doi.org/10.1016/j.ijpharm.2018.01.039
Maté L, Ballent M, Cantón C, Ceballos L, Lifschitz A, Lanusse C, Alvarez L, Liron JP (2018) Assessment of P-glycoprotein gene expression in adult stage of Haemonchus contortus in vivo exposed to ivermectin. Vet Parasitol 264:1–7. https://doi.org/10.1016/j.vetpar.2018.10.011
Mauser AE, Whitlark J, Whitney KM, Lothrop CDJ (1996) A deletion mutation causes hemophilia B in Lhasa Apso dogs. Blood 88:3451–3455. https://doi.org/10.1182/blood.V88.9.3451.bloodjournal8893451
Mavuso S, Marimuthu T, Kumar P, Kondiah PPD, du Toit LC, Choonara YE, Pillay V (2018) In vitro, ex vivo, and in vivo evaluation of a dual pH/redox responsive nanoliposomal sludge for transdermal drug delivery. J Pharm Sci 107:1028–1036. https://doi.org/10.1016/j.xphs.2017.11.011
McGuire P, Howes OD, Stone J, Fusar-Poli P (2008) Functional neuroimaging in schizophrenia: diagnosis and drug discovery. Trends Pharmacol Sci 29:91–98. https://doi.org/10.1016/j.tips.2007.11.005
Mendez N, Liberman A, Corbeil J, Barback C, Viveros R, Wang J, Wang-Rodriguez J, Blair SL, Mattrey R, Vera D, Trogler W, Kummel AC (2017) Assessment of in vivo systemic toxicity and biodistribution of iron-doped silica nanoshells. Nanomedicine 13:933–942. https://doi.org/10.1016/j.nano.2016.10.018
Metzner H, Weimer T, Kronthaler U, Lang W, Schulte S (2009) Genetic fusion to albumin improves the pharmacokinetic properties of Factor IX. Thromb Haemost 102:634–644. https://doi.org/10.1160/TH09-04-0255
Mohamed M, Haider M, Ali M (2011) Buccal mucoadhesive films containing antihypertensive drug: in vitro/in vivo evaluation. J Chem Pharm Res 3:665–686
Narang N, Sharma J (2011) Sublingual mucosa as a route for systemic drug delivery. Int J Pharm Pharm Sci 3:18–22
Novoa B, Figueras A, Zebrafish (2012) Model for the study of inflammation and the innate immune response to infectious diseases. In: Lambris JD, Hajishengallis G (Eds) Current topics in innate immunity II, Springer, New York, pp. 253–275. https://doi.org/10.1007/978-1-4614-0106-3_15.
Ohtsu H, Hori Y, Numayama K, Ishigaki S, Kubota Y, Sakurai E, Hirasawa N, Tanaka S, Ichikawa A, Watanabe T (1999) Assessment of in vivo effects of histamine using histidine decarboxylase (HDC) gene knockout mice. Jpn J Pharmacol 79:19. https://doi.org/10.1016/S0021-5198(19)34105-8
Özdemir S, Çelik B, Sümer E, Acar ET, Üner M (2018) Eplerenone nanoemulsions for treatment of hypertension. Part II: physical stability assessment and in vivo study. J Drug Deliv Sci Technol 45:287–295. https://doi.org/10.1016/j.jddst.2018.03.014
Patel A, Cholkar K, Agrahari V, Mitra AK (2013) Ocular drug delivery systems: an overview. World J Pharmacol 2:47–64. https://doi.org/10.5497/wjp.v2.i2.47
Patel P, Schmieder S, Krishnamurthy K (2016) Research techniques made simple: drug delivery techniques, Part 2: commonly used techniques to assess topical drug bioavailability. J Invest Dermatol 136:e43–e49. https://doi.org/10.1016/j.jid.2016.03.010
Pattabhi S, Lotti SN, Berger MP, Singh S, Lux CT, Jacoby K, Lee C, Negre O, Scharenberg AM, Rawlings DJ (2019) In vivo outcome of homology-directed repair at the HBB gene in HSC using alternative donor template delivery methods. Mol Ther Nucleic Acids 17:277–288. https://doi.org/10.1016/j.omtn.2019.05.025
Peterson CY, Shaterian A, Borboa AK, Gonzalez AM, Potenza BM, Coimbra R, Eliceiri BP, Baird A (2009) The noninvasive, quantitative, in vivo assessment of adenoviral-mediated gene delivery in skin wound biomaterials. Biomaterials 30:6788–6793. https://doi.org/10.1016/j.biomaterials.2009.07.069
Porada CD, Sanada C, Long CR, Wood JA, Desai J, Frederick N, Millsap L, Bormann C, Menges SL, Hanna C, Flores-foxworth G, Shin T, Westhusin ME, Liu W, Glimp H, Zanjani ED, Lozier JN, Pliska V, Stranzinger G, Joerg H, Kraemer DC, Almdida-Porada G (2010) Clinical and molecular characterization of a re-established line of sheep exhibiting hemophilia A. J Thromb Haemost 8:276–285. https://doi.org/10.1111/j.1538-7836.2009.03697.x
Ramkanth S, Chetty CM, Sudhakar Y, Thiruvengadarajan VS, Anitha P, Gopinath C (2018) Development, characterization and in vivo evaluation of proniosomal based transdermal delivery system of Atenolol. Futur J Pharm Sci 4:80–87. https://doi.org/10.1016/j.fjps.2017.10.003
Rençber S, Karavana SY, Yılmaz FF, Eraç B, Nenni M, Özbal S, Pekçetin Ç, Gurer-Orhan H, Hoşgör-Limoncu M, Güneri P, Ertan G (2016) Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis. Int J Nanomedicine 11:2641–2653. https://doi.org/10.2147/IJN.S103762
Rudin M, Weissleder R (2003) Molecular imaging in drug discovery and development. Nat Rev Drug Discov 2:123–131. https://doi.org/10.1038/nrd1007
Ruela A, Perissinato A, Lino M, Mudrik P, Pereira G (2016) Evaluation of skin absorption of drugs from topical and transdermal formulations. Brazilian J Pharm Sci 52:527–544. https://doi.org/10.1016/j.jid.2016.03.010
Sabu C, Raghav D, Jijith US, Mufeedha P, Naseef PP, Rathinasamy K, Pramod K (2019) Bioinspired oral insulin delivery system using yeast microcapsules. Mater Sci Eng C 103:109753. https://doi.org/10.1016/j.msec.2019.109753
Sadarani B, Majumdar A, Paradkar S, Mathur A, Sachdev S, Mohanty B, Chaudhari P (2019) Enhanced skin permeation of methotrexate from penetration enhancer containing vesicles: in vitro optimization and in vivo evaluation. Biomed Pharmacother 114:108770. https://doi.org/10.1016/j.biopha.2019.108770
Shojaei AH (1998) Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharm Sci 1:15–30. https://europepmc.org/abstract/MED/10942969.
Sieber S, Grossen P, Detampel P, Siegfried S, Witzigmann D, Huwyler J (2017) Zebrafish as an early stage screening tool to study the systemic circulation of nanoparticulate drug delivery systems in vivo. J Control Release 264:180–191. https://doi.org/10.1016/j.jconrel.2017.08.023
Sieber S, Grossen P, Bussmann J, Campbell F, Kros A, Witzigmann D, Huwyler J (2019) Zebrafish as a preclinical in vivo screening model for nanomedicines. Adv Drug Deliv Rev 151–152:152–168. https://doi.org/10.1016/j.addr.2019.01.001
Sim DS, Kauser K (2016) In vivo target validation using biological molecules in drug development. In Nielsch U, Fuhrmann U, Jaroch S (Eds) New approaches to drug discovery. Springer International Publishing, Switzerland, pp 59–70. https://doi.org/10.1007/164_2015_17
Singh A, Neupane YR, Mangla B, Kohli K (2019) Nanostructured lipid carriers for oral bioavailability enhancement of exemestane: formulation design, in vitro, ex vivo, and in vivo studies. J Pharm Sci 108:3382–3395. https://doi.org/10.1016/j.xphs.2019.06.003
Spence R, Gerlach G, Lawrence C, Smith C (2008) The behaviour and ecology of the zebrafish, Danio rerio. Biol Rev 83:13–34. https://doi.org/10.1111/j.1469-185X.2007.00030.x
Taktak F, Bütün V, Tuncer C, Demirel HH (2019) Production of LMWH-conjugated core/shell hydrogels encapsulating paclitaxel for transdermal delivery: in vitro and in vivo assessment. Int J Biol Macromol 128:610–620. https://doi.org/10.1016/j.ijbiomac.2019.01.184
Tang C, Prueksaritanont T (2010) Use of in vivo animal models to assess pharmacokinetic drug-drug interactions. Pharm Res 27:1772–1787. https://doi.org/10.1007/s11095-010-0157-z
The C. elegans Sequencing Consortium (1998) Genome sequence of the nematode C. elegans: a platform for investigating biology. Science 282:2012–2018. https://doi.org/10.1126/science.282.5396.2012
Trenktrog T, Müller BW, Specht FM, Seifert J (1996) Enteric coated insulin pellets: development, drug release and in vivo evaluation. Eur J Pharm Sci 4:323–329. https://doi.org/10.1016/0928-0987(95)00162-X
Verma P, Thakur AS, Deshmukh K, Jha AK, Verma S (2010) Routes of drug administration. Int J Pharm Stud Res 1:54–59. https://doi.org/10.1016/B978-008055232-3.60070-4
Wang C, Zhu J, Ma J, Yang Y, Cui X (2019) Functionalized Bletilla striata polysaccharide micelles for targeted intracellular delivery of doxorubicin: in vitro and in vivo evaluation. Int J Pharm 567:118436. https://doi.org/10.1016/j.ijpharm.2019.06.027
Wilber A, Frandsen JL, Wangensteen KJ, Ekker SC, Wang X, McIvor RS (2005) Dynamic gene expression after systemic delivery of plasmid DNA as determined by in vivo bioluminescence imaging. Hum Gene Ther 16:1325–1332. https://doi.org/10.1089/hum.2005.16.1325
Wise RG, Tracey I (2006) The role of fMRI in drug discovery. J Magn Reson Imaging 23:862–876. https://doi.org/10.1002/jmri.20584
Xu J, Lu X, Zhu X, Yang Y, Liu Q, Zhao D, Lu Y, Wen J, Chen X, Li N (2019) Formulation and characterization of spray-dried powders containing vincristine-liposomes for pulmonary delivery and its pharmacokinetic evaluation from in vitro and in vivo. J Pharm Sci 108:3348–3358. https://doi.org/10.1016/j.xphs.2019.05.009
Yang L, Chu J, Fix J (2002) Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm 235:1–15. https://doi.org/10.1016/S0378-5173(02)00004-2
Yang X, Ku T, Sun Z, Liu QS, Yin N, Zhou Q, Faiola F, Liao C, Jiang G (2019) Assessment of the carcinogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin using mouse embryonic stem cells to form teratoma in vivo. Toxicol Lett 312:139–147. https://doi.org/10.1016/j.toxlet.2019.05.012
Yazhiniprabha M, Vaseeharan B (2019) In vitro and in vivo toxicity assessment of selenium nanoparticles with significant larvicidal and bacteriostatic properties. Mater Sci Eng C 103:109763. https://doi.org/10.1016/j.msec.2019.109763
Zeira E, Manevitch A, Khatchatouriants A, Pappo O, Hyam E, Darash-Yahana M, Tavor E, Honigman A, Lewis A, Galun E (2003) Femtosecond infrared laser-an efficient and safe in vivo gene delivery system for prolonged expression. Mol Ther 8:342–350. https://doi.org/10.1016/s1525-0016(03)00184-9
Zhao Y, Raichle ME, Wen J, Benzinger TL, Fagan AM, Hassenstab J, Vlassenko AG, Luo J, Cairns NJ, Christensen JJ, Morris JC, Yablonskiy DA (2017) In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging. Neuroimage 148:296–304. https://doi.org/10.1016/j.neuroimage.2016.12.026
Zon LI, Peterson RT (2005) In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 4:35–44. https://doi.org/10.1038/nrd1606
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Glossary
- Bioavailability
-
It is the rate and extent of drug absorption to the circulatory system of the body from the site of administration.
- Biocompatibility
-
It is the ability of a material being compatible with living tissues.
- Bioluminescence
-
It is the production and emission of light by living organisms.
- First-pass metabolism
-
It is a process that results in the reduction of drug concentration before reaching the systemic circulation when it is administered orally.
- In vitro studies
-
Experiments performed outside of living organisms, such as in glass apparatus.
- In vivo studies
-
Experiments for the determination of effects of the drug or other entities in a living organism like cells, tissues, or whole organisms, especially in animals and humans.
- Pharmacodynamics
-
It is the study of the physiological and biochemical effects of a drug in the body after its administration.
- Pharmacokinetics
-
It is the study of the time course of absorption, distribution, metabolism, and excretion of drugs.
- Solubility
-
It is the maximum amount of solute dissolved per unit volume of a given solvent at equilibrium.
- Systemic delivery
-
It is the administration of drugs to the body of the patient systemically through intravenous, oral, pulmonary, subcutaneous, etc.
- Therapeutic efficacy
-
It is the capacity of a drug or other interventions to produce a therapeutic effect in the body.
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ameena Shirin, V.K., Sankar, R., Kotta, S., Pramod, K. (2020). In Vivo Assessment of the Efficiency of Systemic Delivery. In: Lai, WF. (eds) Systemic Delivery Technologies in Anti-Aging Medicine: Methods and Applications. Healthy Ageing and Longevity, vol 13. Springer, Cham. https://doi.org/10.1007/978-3-030-54490-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-54490-4_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-54489-8
Online ISBN: 978-3-030-54490-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)